Sandbox vidit3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<table class="wikitable"> | <table class="wikitable"> | ||
<tr class="v-firstrow"><th> | <tr class="v-firstrow"><th>Drug</th><th>Adult dosage</th></tr> | ||
< | <th>Inhaled Short Acting β Agonists (SABA)</th> | ||
<tr><td>Albuterol/Bitolterol/Pirbuterol <br> a) Nebulizer solution <br> b) MDI</td><td> <br> ♦ 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed or 10-15 mg/hour continuously. <br> ♦ 4-8 puffs every 20 mins upto 4 hours, then every 1-4 hours as needed. </td></tr> | |||
<tr><td>Levalbuterol <br> a) Nebulizer solution <br> b) MDI </td><td> <br> ♦ 1.25-2.5 mg every 20 mins for 3 doses, then 1.25-5 mg every 1-4 hours as needed. <br> ♦ 4-8 puffs every 20 mins upto 4 hours, then every 1-4 hours as needed. </td></tr> | |||
<th>Anticholinergics</th> | |||
<tr><td>Ipratropium bromide <br> a) Nebulizer solution <br> b) MDI <br> </td><td><br> ♦ 0.5 mg every 20 mins for 3 doses, then as needed. <br> ♦ 8 puffs every 20 mins as needed for upto 3 hours.</td></tr> | |||
<tr><td>Ipratropium with albuterol <br> a) Nebulizer solution (each 3 ml containing 0.5 mg ipratropium and 2.5 mg albuterol) <br> b) MDI (each puff contains 18 mcg ipratropium and 90 mcg albuterol) </td><td> <br> ♦ 3 ml every 20 mins for 3 doses, then as needed. <br> ♦ 8 puffs every 20 mins as needed for 3 hours</td></tr> | |||
<tr><td>Hemodynamics</td><td>RAP normal <br> CI normal</td></tr> | <tr><td>Hemodynamics</td><td>RAP normal <br> CI normal</td></tr> | ||
Revision as of 17:22, 14 January 2014
Drug | Adult dosage |
---|---|
Inhaled Short Acting β Agonists (SABA) | |
Albuterol/Bitolterol/Pirbuterol a) Nebulizer solution b) MDI | ♦ 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed or 10-15 mg/hour continuously. ♦ 4-8 puffs every 20 mins upto 4 hours, then every 1-4 hours as needed. |
Levalbuterol a) Nebulizer solution b) MDI | ♦ 1.25-2.5 mg every 20 mins for 3 doses, then 1.25-5 mg every 1-4 hours as needed. ♦ 4-8 puffs every 20 mins upto 4 hours, then every 1-4 hours as needed. |
Anticholinergics | |
Ipratropium bromide a) Nebulizer solution b) MDI | ♦ 0.5 mg every 20 mins for 3 doses, then as needed. ♦ 8 puffs every 20 mins as needed for upto 3 hours. |
Ipratropium with albuterol a) Nebulizer solution (each 3 ml containing 0.5 mg ipratropium and 2.5 mg albuterol) b) MDI (each puff contains 18 mcg ipratropium and 90 mcg albuterol) | ♦ 3 ml every 20 mins for 3 doses, then as needed. ♦ 8 puffs every 20 mins as needed for 3 hours |
Hemodynamics | RAP normal CI normal |
BNP | Near normal or stable |
Treatment | Oral therapy |
Frequency of evaluation | Q 3 to Q 6 months |
FC assessment | Every clinic visit |
6MWT | Every clinic visit |
Echocardiogram2 | Q 12 months/center dependent |
BNP | center dependent |
RHC | Clinical deterioration and center dependent |
Clinical course | Unstable |
---|---|
Physical examination | Signs of heart failure |
Functional class | IV |
6MWD | Less than 400 m |
Echocardiogram | RV Enlargement |
Hemodynamics | RAP high CI low |
BNP | Elevated/Increasing |
Treatment | Intravenous prostacyclin and/or combination treatment |
Frequency of evaluation | Q 1 to Q 3 months |
FC assessment | Every clinic visit |
6MWT | Every clinic visit |
Echocardiogram2 | Q 6 to Q 12 months/center dependent |
BNP | center dependent |
RHC | Q 6 to Q 12 months or clinical deterioration |